🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Investigational Treatment Acquiring Traction Online

Retatrutide, which remains in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are encouraged to message these profiles privately for source information, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where communities with numerous of members share “before and after” photos, injection guides and claims of rapid British shipping. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is worrisome and could result in users injecting products of uncertain source.

Some experts said the popularity for the experimental drug could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Several influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate medicines, advertising, and consumer laws, risking fines, prosecution or imprisonment.

Service Response and Content Removal

Based on the social media company, the platform has removed violative content and prohibited related keywords and query recommendations. The company stated it was committed to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Research also discovered groups with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, filled with photos of slimming results, positive testimonials and step-by-step guides for mixing or administering at residence.

Within minutes of joining one community, a seller posted WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about body mass, medical conditions or past usage.

Product Details and Pricing

Within these communities, posts show dark colored parcels with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually priced at £160 for 20 milligrams. When questioned how long a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for Telegram said it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Although the research behind this drug is valid, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has already seen individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company investigational product not yet authorized … may expose patients to possibly serious health risks”.